| Pterin–sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents Y Zhao, WR Shadrick, MJ Wallace, Y Wu, EC Griffith, J Qi, MK Yun, ... Bioorganic & medicinal chemistry letters 26 (16), 3950-3954, 2016 | 88 | 2016 |
| The Structural and Functional Basis for Recurring Sulfa Drug Resistance Mutations in Staphylococcus aureus Dihydropteroate Synthase EC Griffith, MJ Wallace, Y Wu, G Kumar, S Gajewski, P Jackson, ... Frontiers in Microbiology 9, 1369, 2018 | 79 | 2018 |
| Antimicrobial resistance in enteric bacteria: current state and next-generation solutions MJ Wallace, SRS Fishbein, G Dantas Gut microbes 12 (1), 1799654, 2020 | 78 | 2020 |
| Ureadepsipeptides as ClpP activators EC Griffith, Y Zhao, AP Singh, BP Conlon, R Tangallapally, WR Shadrick, ... ACS infectious diseases 5 (11), 1915-1925, 2019 | 36 | 2019 |
| Comparative genomics of Bacteroides fragilis group isolates reveals species-dependent resistance mechanisms and validates clinical tools for resistance prediction MJ Wallace, S Jean, MA Wallace, CAD Burnham, G Dantas MBio 13 (1), e03603-21, 2022 | 29 | 2022 |
| Time for some group therapy: update on identification, antimicrobial resistance, taxonomy, and clinical significance of the Bacteroides fragilis group S Jean, MJ Wallace, G Dantas, CAD Burnham Journal of clinical microbiology 60 (9), e02361-20, 2022 | 22 | 2022 |
| Discovery and characterization of the antimetabolite action of thioacetamide-linked 1, 2, 3-triazoles as disruptors of cysteine biosynthesis in gram-negative bacteria MJ Wallace, S Dharuman, DM Fernando, SM Reeve, CT Gee, J Yao, ... ACS infectious diseases 6 (3), 467-478, 2019 | 20 | 2019 |
| Solid-phase synthesis and antibacterial activity of cyclohexapeptide wollamide B analogs LS Tsutsumi, JM Elmore, UT Dang, MJ Wallace, R Marreddy, RB Lee, ... ACS Combinatorial Science 20 (3), 172-185, 2018 | 20 | 2018 |
| Synthesis and Evaluation of Thiazolidine Amide and N‐Thiazolyl Amide Fluoroquinolone Derivatives I Garza, MJ Wallace, D Fernando, A Singh, RE Lee, JS Gerding, ... Archiv der Pharmazie 350 (6), e201700029, 2017 | 16 | 2017 |
| Combating multidrug‐resistant bacteria by integrating a novel target site penetration and receptor binding assay platform into translational modeling Y Lang, NR Shah, X Tao, SM Reeve, J Zhou, B Moya, ARM Sayed, ... Clinical Pharmacology & Therapeutics 109 (4), 1000-1020, 2021 | 13 | 2021 |
| Comparative genomics of Bacteroides fragilis group isolates reveals species-dependent resistance mechanisms and validates clinical tools for resistance prediction. MBio 13 … MJ Wallace, S Jean, MA Wallace, CD Burnham, G Dantas | 9 | 2022 |
| Synthesis and Structure–Activity Relationship of Thioacetamide-Triazoles against Escherichia coli S Dharuman, MJ Wallace, SM Reeve, JB Bulitta, RE Lee Molecules 27 (5), 1518, 2022 | 7 | 2022 |
| Biophysical analysis of the Mycobacteria tuberculosis peptide binding protein DppA reveals a stringent peptide binding pocket DM Fernando, CT Gee, EC Griffith, CJ Meyer, LA Wilt, R Tangallapally, ... Tuberculosis 132, 102157, 2022 | 7 | 2022 |
| Ureadepsipeptides as ClpP activators. ACS Infect. Dis. 5: 1915–1925 EC Griffith, Y Zhao, AP Singh, BP Conlon, R Tangallapally, WR Shadrick, ... | 6 | 2019 |
| Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential. mSphere. 2018; 3 (6). Epub 20181121 C Bulow, A Langdon, T Hink, M Wallace, KA Reske, S Patel, X Sun, ... Epub 20181121 (10.1128), 00588-18, 2018 | 5 | 2018 |
| Tri-petal lilac-like perylene: Asymmetrical substituted platform for regioselective ether-exchange reaction M Zhou, L Zhu, Z Sun, Z Yang, D Cao, Q Li Synlett 28 (16), 2121-2125, 2017 | 3 | 2017 |
| A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden ON Rebeck, MJ Wallace, J Prusa, J Ning, EM Evbuomwan, S Rengarajan, ... Cell Chemical Biology 32 (1), 98-110. e7, 2025 | 2 | 2025 |
| Spontaneous Bacterial Peritonitis Caused by Bordetella hinzii GC Wang, MJ Wallace, G Krishnan, PD Olson, AL Carlson, G Dantas, ... Emerging Infectious Diseases 27 (11), 2966, 2021 | 2 | 2021 |
| Antibiotic Drug Discovery Targeting Bacterial Metabolism MJ Wallace The University of Tennessee Health Science Center, 2019 | 1 | 2019 |
| Commensal-pathogen dynamics structure disease outcomes during Clostridioides difficile colonization SRS Fishbein, AL DeVeaux, S Khanna, AL Ferreiro, J Liao, W Agee, ... Cell Host & Microbe 33 (1), 30-41. e6, 2025 | | 2025 |
Gautam DantasConan Professor of Lab & Genomic Medicine, Dept. of Pathology & Immunology, Washington UniversityVerified email at wustl.edu
